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Myeloid sarcoma is a tumor mass of immature myeloid or granulocytic cells that affects extramedullary anatomic 
sites, including uncommonly the oral cavity. A 24-year-old female was referred for evaluation of a fast growing 
painful gingival swelling lasting 2 weeks, associated with fever, fatigue, and cervical lymphadenopathy. Intraoral 
examination showed a bluish swelling on the right posterior lower gingiva exhibiting necrotic surface. Incisio-
nal biopsy of the gingival lesion displayed diffuse infiltration of undifferentiated tumor cells with granulocytic 
appearance, strongly immunopositive for CD99, myeloperoxidase and Ki-67 (60%), and negative for CD20, CD3, 
CD34 and TdT. Blood tests presented a severe pancytopenia, and genetic analysis confirmed the diagnosis of acute 
promyelocytic leukemia. The final diagnosis was of oral myeloid sarcoma associated with acute promyelocytic 
leukemia with t(15;17). The patient was submitted to chemotherapy but died of the disease one month later. The 
clinicopathologic and immunohistochemical features of the present case are compared with the 89 cases of oral 
myeloid sarcoma previously reported in the English-language literature.
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Introduction
Myeloid sarcoma (MS), also known as granulocytic sar-
coma or chloroma, is a tumor mass of immature myeloid 
cells that usually occurs in an extramedullary site or bone 
of male patients in the sixth decade of life (1). MS has 
been associated with acute myeloid leukemias (AML) or 
other myeloproliferative disorders (2-3). Treatment and 
prognosis of MS depends on the hematological status 
and clinical presentation (4).  
The microscopical features of MS include the presence 
of immature myeloblasts within a dense inflammatory 
background, which are better identified after careful his-
tological and immunohistochemical evaluation (4-5). 
Some markers are useful to confirm an immature mye-
loid phenotype of tumor cells, such as myeloperoxidase 
(MPO), CD68, CD117, CD34, and CD99 (6). 
Oral involvement by MS is uncommon. To the best of 
our knowledge, only 89 cases of oral MS have been pu-
blished in the English-language literature so far, and only 
four of them were associated with acute promyelocytic 
leukemia (1-15). Herein, we report an additional case of 
oral MS in a 24-year-old female with acute promyelo-
cytic leukemia, including a review of the literature.
Fig. 1: Clinical features of oral myeloid sarcoma. (A) Intraoral examination showing pale oral mucosa, blood accumu-
lation within the gingival sulcus of various teeth, and a normal colored swelling on the buccal posterior lower gingiva 
of the right side. (B) Brownish swelling with ulceration on the lingual aspect of the right posterior lower gingiva 
exhibiting also necrotic and bleeding surface.
Fig. 2: Panoramic radiography exhibiting absence of bone involvement.
Case Report
A 24-year-old female was referred by a general dentist 
for evaluation of a fast growing gingival swelling that 
had been present for 2 weeks. The patient reported a 
3-weeks history of fever and fatigue. Physical exami-
nation revealed cervical lymphadenopathy, and intraoral 
examination showed discrete areas of clotted blood wi-
thin the gingival sulcus of some teeth, and a 3 cm pain-
ful brownish swelling with necrotic and bleeding surface 
localized in the right posterior lower gingiva (Fig. 1). 
Radiographic examination of the mandible showed no 
bone involvement (Fig. 2). Under the presumptive clini-
cal diagnosis of lymphoma/leukemia, a blood study was 
requested and the patient was submitted to an incisional 
biopsy. 
The gingival specimen showed a diffuse connective tis-
sue infiltration by poorly differentiated blast-like cells 
intermingled with chronic inflammatory infiltrate. Tu-
mor cells were large, round to oval, with mild to mo-
derately basophilic cytoplasm containing granules, and 
round to folded nuclei with fine chromatin. Occasional 
mitotic figures were found (Fig. 3). By immunohistoche-
mistry, tumor cells were intensely positive for myelope-
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roxidase (dilution 1:5000, polyclonal, Dako, Carpinte-
ria, CA, USA) and CD99 (dilution 1:100, clone 12e7, 
Dako, Carpinteria, CA, USA), and negative for CD20 
(dilution 1:1000, clone L26, Dako, Carpinteria, CA, 
USA), CD3 (dilution 1:500, polyclonal, Dako, Carpin-
teria, CA, USA), CD34 (dilution 1:50, clone QBEnd10, 
Dako, Carpinteria, CA, USA), and TdT (dilution 1:50, 
polyclonal, Dako, Carpinteria, CA, USA). Ki-67 (dilu-
tion 1:100, clone MIB-1, Dako, Carpinteria, CA, USA) 
labeling was high, with 60% of tumor cells positive 
(Figure 3).  Blood findings showed pancytopenia (0.7 
x109/L leucocytes, 31 x 109/L platelets, hemoglobin 6.3 
g/dl, and hematocrit 18.6%) and the specific chromoso-
mal translocation t(15;17) revealed by genetic analysis 
confirmed the diagnosis of acute promyelocytic leuke-
mia with recurrent genetic abnormality. The final diag-
nosis of the oral lesion was myeloid sarcoma associated 
with acute promyelocytic leukemia with t(15;17). The 
patient was then referred to a hematology-oncology ser-
vice, and submitted to chemotherapy including all trans 
retinoic acid (ATRA), idarubicin, and cytarabine. Unfor-
tunately, the patient died one month later after severe 
hemorrhagic episodes.
Fig. 3: Histopathological and immunohistochemical features of oral myeloid sarcoma. (A) Diffuse infiltration of 
the gingival connective tissue by sheets of poorly differentiated hematopoietic cells, exhibiting dense nuclei, and 
basophilic cytoplasm within a background of capillary proliferation and abundant erythrocyte extravasation (HE, 
100X). (B) The infiltrate is composed mostly of myelocytes promyelocytes, and myeloblasts. The cells are large 
in size and round to oval in shape, and the cytoplasm was mild to moderately basophilic (HE, 400X). Tumor cells 
showed a strong positivity for (C) myeloperoxidase, and (D) Ki-67 (Immunoperoxidase, 400X). 
Discussion
Myeloid sarcoma (MS) is an extramedullary solid tumor 
composed of myeloblasts or immature cells of granulo-
cytic lineage and erythroid precursors (2-3). First descri-
bed by Burns and King in 1811, MS is also referred as 
“chloroma” due its green colored appearance when ex-
posed to air, by the presence of myeloperoxidase in the 
tumor cells (1). Since the greenish color is not a consis-
tent clinical finding and considering a proved granulo-
cytic origin, the terms granulocytic sarcoma or myeloid 
sarcoma are preferably adopted by most authors (1-3). 
MS is mainly found in the bone and soft tissues, but 
it may affect virtually any site of the body such as the 
skin, lymph nodes, orbit and eye, oral cavity, bronchi, 
pericardium, peritoneum, gastrointestinal tract, kidney, 
reproductive organs, breast, and bladder (1-4). Conside-
ring the 89 cases of oral MS previously published in the 
English literature, the average age of the patients is 45 
years (ranging from 1 to 89 years), with slight predilec-
tion for females (1,2:1). The mandible is the most com-
mon affected site (28 cases), followed by maxilla (20 ca-
ses), gingiva (13 cases), and palate (seven cases) (1-15). 
MS affected multiple intraoral anatomical sites in eight 
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cases, six of them with concomitant involvement of 
maxilla and mandible (5,7,8,11,13-15). The most com-
mon clinical feature of oral MS is a painful swelling or 
nodule with reddish to brownish-colored ulcerated sur-
face. From all cases reviewed from the literature, only 
five exhibited evident greenish coloration (1,2,4,10,12). 
The clinical differential diagnosis is wide, ranging from 
lymphoma, squamous cell carcinoma and sarcomas to 
benign reactive or inflammatory lesions. The diagnosis 
of oral MS is usually based on histopathological and 
immunohistochemical analysis, and a history of symp-
toms associated with hematological diseases that might 
be absent (7-9). In the present case, the patient was a 
24-years-old female patient, who was diagnosed conco-
mitantly with a subtype of acute myeloid leukemia. The 
clinical appearance of the present case was consistent 
with a malignant tumor, showing an ulcerated and pa-
inful brownish-colored swelling in the lingual aspect of 
the lower posterior gingiva with no bone involvement. 
The identification of pale-appearing mucosae and areas 
of coagulated blood within the gingival sulcus led us to 
suspect of a leukemia, which was confirmed after blood 
test and genetic analyses.      
Microscopically, oral MS exhibits variable numbers of 
primitive, poorly differentiated cells with granular cyto-
plasm, round to oval nuclei with well-defined membrane 
and prominent nucleoli, intermingled with reactive infla-
mmatory infiltrate. The tumor cells show different stages 
of myeloid differentiation, including the eosinophilic 
myelocytes and blastic cells with minimal granulocytic 
differentiation (9). The microscopical differential diag-
nosis of oral MS includes diffuse large B-cell lympho-
ma, Burkitt lymphoma, lymphoblastic lymphoma, and 
poorly-differentiated squamous cell carcinoma (7). The 
histopathological diagnosis can be difficult, especially in 
cases of prominent reactive inflammatory infiltrate bac-
kground and limited correlation with clinical features. 
Immunohistochemical analysis is necessary to prove the 
granulocytic origin of tumor cells (6), which are usually 
positive for myeloperoxidase (MPO) and CD99, impor-
tant markers for the diagnosis of myeloid sarcoma (9). 
In the present case, the identification of the granulocytic 
appearance of the tumor cells was difficult on hema-
toxylin and eosin-stained slides, and the immunohisto-
chemical positivity for myeloperoxidase in a cytoplas-
mic pattern and for CD99 in a membrane pattern was 
essential to achieve the final diagnosis. 
MS may precede, coexist with, or follow a presentation 
of acute myeloid leukemia (AML), but might also result 
from an acute blastic transformation of myelodysplastic 
syndromes or myeloproliferative neoplasms (6). In fact, 
the diagnosis of MS is currently considered synonym 
of AML, and the same chemotherapeutic regimens are 
used (6). Acute promyelocytic leukaemia (APL; also 
previously known as AML-M3) accounts for around 8% 
of all AML cases, occurring mainly in early adulthood. 
APL is characterized by the predominance of abnor-
mal promyelocytes in the bone marrow and identifica-
tion of a specific chromosomal translocation t(15;17)
(q24.1;q21.1) resulting in a fusion transcript between 
the genes promyelocytic (PML on chromosome 15) and 
retinoic acid receptor alpha (RARA on chromosome 17). 
The most common diseases associated with oral MS are 
AML (43 cases), followed by myelodysplastic syndrome 
(11 cases), and chronic myeloid leukemia (seven cases), 
nevertheless 14 patients with oral MS did not present 
nor developed associated leukemia or myelodysplastic 
neoplasms (1-15). 
Approximately 90% of patients with APL have shown 
complete remission of disease after the advent of ATRA 
and anthracycline-based therapeutic regimens (7). 
However, the rate of early induction death is still high in 
patients with APL, and one of the most common causes 
is hemorrhage, as observed in the present case.  Only 
four out of 89 cases of oral MS reported in the English 
literature were associated with APL (3), and one died of 
the disease, as the present case. From all oral MS cases 
reported in the literature, 53 patients died of disease, 16 
had no evidence of disease, and 11 were alive with di-
sease (1-15).  
In summary, oral MS is uncommon, with clinical and 
microscopical features that may mimic inflammatory 
lesions or other malignant tumors. Careful morphologi-
cal and immunohistochemical analyses, correlating with 
clinical data are necessary to establish the diagnosis of 
oral MS. Clinicians and oral pathologists should consi-
der MS when evaluating gingival swellings and ulce-
rations in patients with clinical findings suggestive of 
hematological abnormalities. 
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